Hussman Strategic Advisors, Inc. Amgen Inc Transaction History

Hussman Strategic Advisors, Inc.

$351 Million
Q2 2024

A detailed history of Hussman Strategic Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 12,600 shares of AMGN stock, worth $4.07 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

12,600

Previous 10,500 20.0%

Holding current value

$4.07 Million

Previous $2.99 Million 31.86%

% of portfolio

1.12%

Previous 0.72%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $551,775 - $670,551	2,100 Added 20.0%	12,600 $3.94 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $1.13 Million - $1.36 Million	4,200 Added 66.67%	10,500 $2.99 Million
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $2.42 Million - $2.73 Million	-9,450 Reduced 60.0%	6,300 $1.81 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $32,797 - $40,719	150 Added 0.96%	15,750 $4.23 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $21,427 - $25,337	100 Added 0.65%	15,600 $3.46 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $709,993 - $902,131	-3,100 Reduced 16.67%	15,500 $4.07 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $1.85 Million - $2.09 Million	8,250 Added 79.71%	18,600 $4.19 Million
Q2 2022 Sep 12, 2022	BUY	$230.71 - $256.74 $588,310 - $654,687	2,550 Added 32.69%	10,350 $2.52 Million
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $570,102 - $630,682	-2,600 Reduced 25.0%	7,800 $1.89 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $218,768 - $250,360	1,100 Added 11.83%	10,400 $2.34 Million
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $1.19 Million - $1.32 Million	-5,100 Reduced 35.42%	9,300 $2.27 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $466,011 - $543,060	2,100 Added 17.07%	14,400 $3.58 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $1.56 Million - $1.86 Million	7,200 Added 141.18%	12,300 $2.83 Million
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $1.2 Million - $1.33 Million	5,100 New	5,100 $1.3 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $3.07 Million - $3.76 Million	-15,500 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $2.82 Million - $3.75 Million	15,500 New	15,500 $3.14 Million
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $993,352 - $1.28 Million	-5,250 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $43,527 - $52,155	250 Added 5.0%	5,250 $1.02 Million
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $2.5 Million - $2.93 Million	-15,000 Reduced 75.0%	5,000 $921,000
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $3.57 Million - $4.17 Million	20,000 New	20,000 $3.89 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Account

Hussman Strategic Advisors, Inc. Amgen Inc Transaction History